Get AMB-CHMINACA essential facts below. View Videos or join the AMB-CHMINACA discussion. Add AMB-CHMINACA to your topic list for future reference or share this resource on social media.
Legal status
Legal status
CAS Number
PubChem CID
Chemical and physical data
Formula C21H29N3O3
Molar mass 371.5 g/mol
3D model (JSmol)

AMB-CHMINACA (also known as MA-CHMINACA) is an indazole-based synthetic cannabinoid[1] that is a potent agonist of the CB1 receptor and has been sold online as a designer drug.[2][3][4]

Legal status

AMB-CHMINACA is listed in the Fifth Schedule of the Misuse of Drugs Act (MDA) and therefore illegal in Singapore as of May 2015.[5]

See also


  1. ^ Akamatsu, Shigeki; Yoshida, Masashi (January 2016). "Fragmentation of synthetic cannabinoids with an isopropyl group or a tert-butyl group ionized by electron impact and electrospray". Journal of Mass Spectrometry. 51 (1): 28-32. doi:10.1002/jms.3722. 
  2. ^ "MA-CHMINACA". Cayman Chemical. Retrieved 2015. 
  3. ^ "MA-CHMINACA". Southern Association of Forensic Scientists. Retrieved 2015. 
  4. ^ Samuel D Banister; et al. (July 2016). "The pharmacology of valinate and tert-leucinate synthetic cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and their analogues". ACS Chemical Neuroscience. 7: 1241-54. doi:10.1021/acschemneuro.6b00137. PMID 27421060. 
  5. ^ "CNB NEWS RELEASE". Central Narcotics Bureau (CNB). 30 April 2015. Retrieved 2015. 

  This article uses material from the Wikipedia page available here. It is released under the Creative Commons Attribution-Share-Alike License 3.0.



Top US Cities